Candida Albicans News and Research

RSS
Merck’s MF/F Phase III study data presented at AAAAI annual meeting

Merck’s MF/F Phase III study data presented at AAAAI annual meeting

Rituximab treatment reduces patients' response to pneumonia vaccine

Rituximab treatment reduces patients' response to pneumonia vaccine

American Biotech Labs' ASAP Antibacterial Silver Gel receives FDA 510(k) medical device clearance

American Biotech Labs' ASAP Antibacterial Silver Gel receives FDA 510(k) medical device clearance

Antibiotic effects of pumpkin may help fight yeast infections

Antibiotic effects of pumpkin may help fight yeast infections

Propolis exhibits antioxidant and anti-microbial properties that are beneficial to human health

Propolis exhibits antioxidant and anti-microbial properties that are beneficial to human health

Preachers Coffee signs agreement to enhance its nutraceutical-health marketing strategy

Preachers Coffee signs agreement to enhance its nutraceutical-health marketing strategy

NovaBay's Aganocide compounds effective against multidrug-resistant bacteria

NovaBay's Aganocide compounds effective against multidrug-resistant bacteria

Microbe's multilayer defence mechanisms could treat fungal infections

Microbe's multilayer defence mechanisms could treat fungal infections

Same-sex mating found in most common human fungal pathogen Candida albicans

Same-sex mating found in most common human fungal pathogen Candida albicans

Tamoxifen kills fungus cells and may prevent them from causing disease

Tamoxifen kills fungus cells and may prevent them from causing disease

Targeted approach to kill specific disease-causing bacteria in the mouth

Targeted approach to kill specific disease-causing bacteria in the mouth

Tea tree oil and silver effective in treating skin infections

Tea tree oil and silver effective in treating skin infections

Basis of immunity to oral thrush, common in AIDS, identified by UB researchers

Basis of immunity to oral thrush, common in AIDS, identified by UB researchers

RHEI Pharmaceuticals starts final trial of Tibozole in China

RHEI Pharmaceuticals starts final trial of Tibozole in China

New strategy to treat human infections caused by the yeast Candida albicans

New strategy to treat human infections caused by the yeast Candida albicans

NanoBio demonstrates new topical approach to treating nail fungus that circumvents problems with current therapy

NanoBio demonstrates new topical approach to treating nail fungus that circumvents problems with current therapy

New discovery on Candida infections

New discovery on Candida infections

Alligator blood may provide a source of powerful new antibiotics

Alligator blood may provide a source of powerful new antibiotics

Alligator blood extract promises to help fight superbugs

Alligator blood extract promises to help fight superbugs

NanoBio completes interim analysis of phase 2 clinical trial in onychomycosis

NanoBio completes interim analysis of phase 2 clinical trial in onychomycosis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.